Kyorin Pharmaceutical (4569.T) traded up 0.71 % during a 24 hours period ending at 12:10 PM Central Europe on Tuesday 27th. One Kyorin Pharmaceutical stock can currently be bought for about JPY 1,111 on popular exchanges. Current supply of Kyorin Pharmaceutical stocks is 57.4 mn. Kyorin Pharmaceutical has a current market capitalization of JPY 65.1 bn and approximately JPY 96.8 mn worth of Kyorin Pharmaceutical was traded on exchanges in the last 24 hours. Since last month end, Kyorin Pharmaceutical has traded -0.09 % down. Simple moving average of last 200 days is at JPY 1,364.76. The highest price of past 52 weeks was recorded at JPY 1,725 on 02/27/2026. 52 weeks low was at JPY 1,046 on 10/07/2026.

Here is how related stocks have performed in the past 24 hours:

  • Oiles (6282.T) traded up 0.59 % and now trades at JPY 2,722. Oiles has a market capitalisation of JPY 77.4 bn. Oiles has a current price to earnings ratio of 16.24.

  • Shofu (7979.T) traded up 0.73 % and now trades at JPY 2,213. Shofu has a market capitalisation of JPY 78.1 bn. Shofu has a current price to earnings ratio of 12.79.

  • Hokkaido Gas (9534.T) traded up 3.2 % and now trades at JPY 913. Hokkaido Gas has a market capitalisation of JPY 77.4 bn. Hokkaido Gas has a current price to earnings ratio of 8.25.

  • Siix (7613.T) traded down -0.73 % and now trades at JPY 1,646. Current market capitalisation for Siix is JPY 77.5 bn. Current price/earnings ratio for Siix is 19.77.

  • Kintetsu Dept Store (8244.T) traded up 0.99 % and now trades at JPY 1,897. Current market capitalisation for Kintetsu Dept Store is JPY 77.6 bn. Current price/earnings ratio for Kintetsu Dept Store is 33.17.

About Kyorin Pharmaceutical

Kyorin Pharmaceutical Co., Ltd. is a health care company operating in the pharmaceutical sector of Japan’s industry. The company produces and distributes prescribed medicine and quasi-drugs, as well as diagnostic drugs. Beyond that, Kyorin also manufactures and markets medical tools and equipment, health foods, and cosmetics, and is actively developing medical products in collaboration with other pharmaceutical companies. Their main operations are conducted in Japan, and they can be accessed through their website at www.kyorin-gr.co.jp . They are listed on the Tokyo Stock Exchange. Their Initial Public Offering (IPO) date is 08th April 1999.